GCMTX
Price
$37.01
Change
+$0.42 (+1.15%)
Updated
Sep 26 closing price
Net Assets
1.11B
VEXMX
Price
$158.87
Change
+$1.43 (+0.91%)
Updated
Sep 26 closing price
Net Assets
81.53B
Interact to see
Advertisement

GCMTX vs VEXMX

Header iconGCMTX vs VEXMX Comparison
Open Charts GCMTX vs VEXMXBanner chart's image
Goldman Sachs Mid Cap Value I
Price$37.01
Change+$0.42 (+1.15%)
VolumeN/A
Net Assets1.11B
Vanguard Extended Market Index Investor
Price$158.87
Change+$1.43 (+0.91%)
VolumeN/A
Net Assets81.53B
GCMTX vs VEXMX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GCMTX vs. VEXMX commentary
Sep 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GCMTX is a Buy and VEXMX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEXMX has more cash in the bank: 81.5B vs. GCMTX (1.11B). VEXMX (0.95) and GCMTX (0.92) have matching dividends . GCMTX was incepted earlier than VEXMX: GCMTX (18 years) vs VEXMX (38 years). GCMTX (0.95) is less costly to investors than VEXMX (0.19). GCMTX is a more actively managed with annual turnover of: 56.00 vs. VEXMX (11.00). GCMTX has a lower initial minimum investment than VEXMX: GCMTX (0) vs VEXMX (3000). VEXMX annual gain was more profitable for investors over the last year : 15.56 vs. GCMTX (0.62). VEXMX return over 5 years is better than : 67.01 vs. GCMTX (30.39).
GCMTXVEXMXGCMTX / VEXMX
Total Expense Ratio0.940.19495%
Annual Report Gross Expense Ratio0.950.19500%
Fund Existence18 years38 years-
Gain YTD7.46210.38172%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.11B81.5B1%
Annual Yield % from dividends0.920.9596%
Returns for 1 year0.6215.564%
Returns for 3 years18.1766.0927%
Returns for 5 years30.3967.0145%
Returns for 10 years11.53169.457%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INKT13.960.35
+2.57%
MiNK Therapeutics Inc
RRC37.650.33
+0.88%
Range Resources Corp
TDACU10.460.06
+0.58%
Translational Development Acquisition Corp
TPB98.030.01
+0.01%
Turning Point Brands
PSBD12.13-0.16
-1.30%
Palmer Square Capital BDC